Coagulation profile changes due to thromboprophylaxis and platelets in trauma patients at high-risk for venous thromboembolism

American Surgeon

Volumn 81, Issue 7, 2015, Pages 663-664

  Casey J, Allen ^a   Murray, Clark R ^a   Meizoso, Jonathan P ^a   Juliet J, Ray ^a   Laura F, Teisch ^a   Xiomara, Ruiz ^a   Mena M, Hanna ^a   Gerardo A, Guarch ^a   Manning, Ronald J ^a   Livingstone, Alan S ^a   Enrique, Ginzburg ^a   Schulman, Carl I ^a   Namias, Nicholas ^a   Proctor, Kenneth G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; ANTITHROMBOCYTIC AGENT;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLUNT TRAUMA; CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERCOAGULABILITY; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; THROMBOSIS PREVENTION; TRAUMATIC BRAIN INJURY; VENOUS THROMBOEMBOLISM; AGED; BLOOD; INJURY; MIDDLE AGED; PHYSIOLOGY; RISK ASSESSMENT; THROMBOCYTE;

AGED; BLOOD COAGULATION; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK ASSESSMENT; THROMBELASTOGRAPHY; VENOUS THROMBOEMBOLISM; WOUNDS AND INJURIES;

EID: 84936933015     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008;28:370-2.
2. Van Haren RM, Valle EJ, Thorson CM, et al. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism. J Trauma Acute Care Surg. 2014;76:443-9.
3. Acosta JA, Yang JC, Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. JACS 1998;186:528-33.
4. Geerts WH, Code KI, Jay RM, et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994;331:1601-6.
5. O'Malley KF, Ross SE. Pulmonary embolism in major trauma patients. J Trauma 1990;30:748-50.
6. Jobin S, Kalliainen L, Adebayo L, et al. Venous thromboembolism prophylaxis. Bloomington, MN: Institute for Clinical Systems Improvement (ICSI), Nov 2012, p. 51.
7. Toker S, Hak DJ, Morgan SJ. Deep Vein Thrombosis Prophylaxis in Trauma Patients. Thrombosis 2011;2011:505373.
8. Paffrath T, Wafaisade A, Lefering R, et al. Venous thromboembolism after severe trauma: incidence, risk factors and outcome. Injury 2010;41:97-101.
9. Greenfield LJ, Proctor MC, Rodriguez JL, et al. Posttrauma thromboembolism prophylaxis. J Trauma 1997;42:100-3.
10. Barrera LM, Perel P, Ker K, et al. Thromboprophylaxis for trauma patients. Cochrane Database Syst Rev 2013;3:CD008303.
11. Harr JN, Moore EE, Chin TL, et al. Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg 2013;74:756-62, discussion 62-5.
12. Joseph B, Pandit V, Meyer D, et al. The significance of platelet count in traumatic brain injury patients on antiplatelet therapy. J Trauma Acute Care Surg. 2014;77:417-21.
13. Briggs A, Gates JD, Kaufman RM, et al. Platelet dysfunction and platelet transfusion in traumatic brain injury. J Surg Res 2015;193:802-6.
14. Branco BC, Inaba K, Ives C, et al. Thromboelastogram evaluation of the impact of hypercoagulability in trauma patients. Shock 2014;41:200-7.
15. Schreiber MA, Differding J, Thorborg P, et al. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma 2005;58:475-80, discussion 480-1.
16. Azu MC, McCormack JE, Huang EC, et al. Venous thromboembolic events in hospitalized trauma patients. Am Surg 2007;73:1228-31.
17. Knudson MM, Collins JA, Goodman SB, et al. Thromboembolism following multiple trauma. J Trauma 1992;32:2-11.
18. Knudson MM, Ikossi DG, Khaw L, et al. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg 2004; 240:490-6, discussion 6-8.
19. Shackford SR, Davis JW, Hollingsworth-Fridlund P, et al. Venous thromboembolism in patients with major trauma. Am J Surg 1990;159:365-9.
20. Holley AD, Reade MC. The 'procoagulopathy' of trauma: too much, too late? Curr Opin Crit Care 2013;19:578-86.
21. Kornblith LZ, Kutcher ME, Redick BJ, et al. Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis. J Trauma Acute Care Surg 2014;76:255-6;discussion 62-3.
22. Harr JN, Moore EE, Ghasabyan A, et al. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock 2013;39: 45-9.
23. Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009;67:266-75, discussion 75-6.
24. Clagett GP, Anderson FA Jr, Geerts W, et al. Prevention of venous thromboembolism. Chest 1998;114(Suppl):531S-60S.
25. Collaborative overview of randomised trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:235-46.
26. Collins R, Baigent C, Sandercock P, et al. Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration. BMJ 1994;309:1215-7.
27. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-302.
28. Harr JN, Moore EE, Johnson J, et al. Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients. Crit Care Med 2013;41:399-404.